James Hoekel

Dr. James Hoekel

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
DADamien Abreu
Damien Abreu
SSStephen I Stone
Stephen I Stone
TPToni S. Pearson
Toni S. Pearson
RBRobert C. Bucelli
Robert C. Bucelli
ASAshley N. Simpson
Ashley N. Simpson
FUFumihiko Urano
Fumihiko Urano
BACKGROUND: Wolfram syndrome is a rare ER disorder characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration. Although there is no treatment for Wolfram syndrome, preclinical studies in cell and rodent models suggest that therapeutic strategies targeting ER calcium homeostasis, including dantrolene sodium, may be beneficial. METHODS: Based on results from preclinical studies on dantrolene sodium and ongoing longitudinal studies, we assembled what we believe is the first-ever clinical trial in pediatric and adult Wolfram syndrome patients with an open-label phase Ib/IIa trial design. The primary objective was to assess the safety and tolerability of dantrolene sodium in adult and pediatric Wolfram syndrome patients. Secondary objectives were to evaluate the efficacy of dantrolene sodium on residual pancreatic β cell functions, visual acuity, quality-of-life measures related to vision, and neurological functions. RESULTS: Dantrolene sodium was well tolerated by Wolfram syndrome patients. Overall, β cell functions were not significantly improved, but there was a significant correlation between baseline β cell functions and change in β cell responsiveness ( R 2 , P = 0.004) after 6-month dantrolene therapy. Visual acuity and neurological functions were not improved by 6-month dantrolene sodium. Markers of inflammatory cytokines and oxidative stress, such as IFN-γ, IL-1β, TNF-α, and isoprostane, were elevated in subjects. CONCLUSION: This study justifies further investigation into using dantrolene sodium and other small molecules targeting the ER for treatment of Wolfram syndrome. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02829268 FUNDING: NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK112921, DK113487, DK020579), NIH/National Center for Advancing Translational Sciences (NCATS) (TR002065, TR000448), NIH training grant (F30DK111070), Silberman Fund, Ellie White Foundation, Snow Foundation, Unravel Wolfram Syndrome Fund, Stowe Fund, Eye Hope Foundation, Feiock Fund, Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from NIH/NCATS, Bursky Center for Human Immunology & Immunotherapy Programs.

16 July 2022 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
BOBliss E. O'BRyhim
Bliss E. O'BRyhim
ASAmjad Samara
Amjad Samara
LCLing Chen
Ling Chen
THTamara Hershey
Tamara Hershey
LTLawrence Tychsen
Lawrence Tychsen
JHJames Hoekel
James Hoekel

16 October 2021 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
LTLawrence Tychsen
Lawrence Tychsen
MRMargaret Reynolds
Margaret Reynolds
JHJames Hoekel
James Hoekel
An abstract is unavailable. This article is available as a PDF only.

5 June 2020
Verified
Book Chapter
Closed access
PDF file
JHJames Hoekel
James Hoekel

31 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MRMargaret Reynolds
Margaret Reynolds
NFNicholas Faron
Nicholas Faron
JHJames Hoekel
James Hoekel
LTLawrence Tychsen
Lawrence Tychsen
Children with autism spectrum disorder (ASD) may have impaired vision from high refractive errors: near-sighted-myopia or far-sighted-hyperopia and aversion to spectacles or contact lenses. Refractive surgery can restore sharp vision and eliminate the need for spectacles or contact lenses. Restoration of sharp vision may improve ASD behaviors. Data were collated retrospectively for 267 children with refractive errors and neurodevelopmental disorders (NDD) diagnosed as ASD alone or NDD with ASD-like behaviors. Surgery was either laser photo-refractive keratectomy (PRK; 131 children), implantation of a phakic intra ocular lens (pIOL; 129 children) or removal of the crystalline lens and implantation of an IOL (refractive lens exchange, RLE; 21 children) under general anesthesia. Median age was 10.9 yrs. and median follow-up 3.1 yrs. Pre-operative refractive errors ranged from a mean +7.5 ± 0.9 D to -14.3. ± 4.8 D. Surgery corrected 87% to normal focal length (± 1 D). Visual acuity improved an average 0.6 logMAR. Social interactions and ASD behaviors improved in 55% (146/267) of the treated children (p < .01), including school performance; motor skills; depth perception; repetitive or stereotyped movements; anxiety/fear; and attention. Refractive surgery improves both visual function and behaviors in the majority of highly near-sighted or far-sighted children with ASD.